News & Publications


Learn more about Prous Institute and our progress in drug discovery, technology, industry partnerships, collaborations and scientific articles.

Prous Institute Symmetry presented at BIOtech Japan Annual Meeting (Tokyo, May 13-15, 2015)

30 April 2015.  Ryoka Systems, distributor for Prous Institute for Biomedical Research in Japan, has been invited to speak at the BIOtech 2015, part of Asia’s largest Bio event, Life Science World. On May 14, 2015 (Thu) 12:20-13:20, Atsushi Kanou, General Manager, Computational Science Dept., will present “Prous Institute Symmetry: Computational approach in drug discovery”, highlighting applications of the platform through a series of case studies.

Developed by Prous Institute, Symmetry is the world’s first integrated in silico solution for drug discovery and safety screening. The platform integrates models for a wide range of efficacy, toxicology and human adverse events endpoints. Symmetry’s Global Mechanism of Action (GMoA) model predicts on- and off-target activities of small molecules and is based on an expertly-curated training set of 1 million compounds covering 750 mechanisms of action. Symmetry is a powerful tool for hypothesis generation and guidance in drug discovery and lead optimization to minimize off-target liabilities and is used by global pharmaceutical and biotech organizations to increase research productivity.  

For further information or to schedule a meeting during the conference, please contact